Related Experiment Video
Updated: Jul 19, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Community acquired methicillin resistant Staphylococcus aureus: A Wisconsin perspective
1Dept of Medical Microbiology/Immunology, University of Wisconsin Medical School, 1300 University Ave, Madison, WI 53706, USA. rap@facstaff.wisc.edu
Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infections are a significant public health concern in the US, leading to serious illness and death. This paper highlights key cases observed in Wisconsin.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) has emerged as a critical pathogen.
- Increasing rates of CA-MRSA infections are associated with substantial morbidity and mortality across the United States.
Observation:
- This manuscript presents illustrative clinical cases of CA-MRSA infections.
- Cases were specifically observed and documented within the state of Wisconsin.
Findings:
- The presented cases underscore the severe clinical impact of CA-MRSA.
- Geographic patterns and specific case details offer insights into local epidemiology.
Implications:
- Understanding regional CA-MRSA trends is crucial for effective public health strategies.
- These case examples can inform clinical management and prevention efforts for CA-MRSA nationwide.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Staphylococcal Skin Infections
Mechanism of Antibiotic Resistance in MRSA
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Development of Antibiotic Resistance
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...